Study of NIB101 in Participants With Advanced Solid Tumors
Clinical trial NCT05192174 · TERMINATED
Trial details
- NCT number
- NCT05192174
- Sponsor
- Noile-Immune Biotech, Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2025-05-16
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.